WILMINGTON, Del., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing access to great healthcare to everyone on Medicare, today announced that it will release its financial results after the market closes on Tuesday, November 4, 2025. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial ...

Core Insights - Clover Health Investments, Corp. reported strong financial results for Q2 2025, highlighting significant membership and revenue growth, along with sustained profitability metrics [2][3][4] - The company's technology-first model is credited for driving better care management and improved health outcomes for members, particularly in Medicare Advantage plans [3][20] - Clover Health updated its full-year 2025 guidance, maintaining insurance revenue expectations while improving projections for adjusted SG&A and membership growth [10][4] Financial Performance - Q2 2025 insurance revenue reached $469.8 million, a 34.3% increase from $349.9 million in Q2 2024 [4][3] - Total revenues for Q2 2025 were $477.6 million, up 34% year-over-year [4][3] - Average Medicare Advantage membership increased by 31.8% year-over-year to 105,494 [4][3] - Adjusted net income from continuing operations was $16.7 million, down 53.5% from $35.9 million in Q2 2024 [4][3] - Adjusted EBITDA for Q2 2025 was $17.1 million, a decrease of 52.8% compared to $36.2 million in Q2 2024 [4][3] Membership and Revenue Guidance - The company expects average Medicare Advantage membership to be between 104,000 and 108,000 for the full year 2025, representing a 32% growth year-over-year at the midpoint [4][10] - Insurance revenue guidance for 2025 is maintained at $1.800 billion to $1.875 billion, indicating a 37% growth year-over-year at the midpoint [10][4] - Adjusted SG&A is projected to be between $335 million and $345 million, improving as a percentage of total revenues to 18% - 19% [10][4] Operational Metrics - The Insurance Benefits Expense Ratio (BER) for Q2 2025 was 88.4%, up from 76.1% in Q2 2024 [4][3] - The company reported a net loss from continuing operations of $10.6 million for Q2 2025, compared to a net income of $7.2 million in Q2 2024 [4][3] - Total cash, cash equivalents, and investments decreased by 19.4% to $389.3 million from $482.8 million year-over-year [4][3]

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company utilizes its software platform, Clover Assistant, to aggregate patient data across the healthcare ecosystem, enhancing clinical decision-making and improving health outcomes through early identification and management of chronic diseases [2] Business Strategy - Clover Health offers PPO and HMO Medicare Advantage plans across several states, with a particular emphasis on its flagship wide-network, high-choice PPO plans [2] - The company extends its data-driven technology platform to healthcare providers outside its Medicare Advantage plan through its subsidiary, Counterpart Health, aiming to improve patient outcomes and reduce healthcare costs on a national scale [2] Recent Developments - The Chief Financial Officer of Clover Health, Peter Kuipers, is scheduled to present at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 11:00 a.m. Eastern Time [1]

Core Insights - Clover Health Investments, Corp. has appointed Joseph Oldakowski as Vice President of Finance and Controller, who will oversee corporate accounting and financial reporting [1][4] - Oldakowski brings nearly 20 years of experience in finance and accounting, having previously served at Point32Health and EmblemHealth [2][3] - Clover Health focuses on providing accessible healthcare to Medicare recipients, utilizing its software platform, Clover Assistant, to improve health outcomes [5] Company Overview - Clover Health is a physician enablement technology company dedicated to enhancing healthcare access for Medicare beneficiaries, particularly seniors [5] - The company offers PPO and HMO Medicare Advantage plans across several states, emphasizing a wide-network, high-choice PPO plan [5] - Clover Assistant aggregates patient data to support clinical decision-making and manage chronic diseases, demonstrating positive impacts on medication adherence and chronic conditions [5] Leadership Insights - CFO Peter Kuipers highlighted Oldakowski's expertise in finance transformations and integrity as key attributes for Clover's growth [4] - Oldakowski expressed enthusiasm for joining Clover Health, emphasizing the importance of accessible and high-quality healthcare [4]

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare beneficiaries, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes through early identification and management of chronic diseases [2] - Clover Health offers PPO and HMO Medicare Advantage plans across several states, with a particular emphasis on its wide-network, high-choice PPO plans [2] Upcoming Financial Results - Clover Health will release its financial results for the second quarter of 2025 after market close on August 5, 2025 [1] - A conference call and webcast will be held at 5:00 p.m. Eastern Time on the same day to discuss the company's business and financial performance [1][3] - Investors can access the conference call via telephone or through a live and archived webcast available on the company's Investor Relations website [3]

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [5] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes through early identification and management of chronic diseases [5] Recent Developments - Clover Health announced its inclusion in the Russell 3000® Index, effective June 30, 2025, as part of the annual reconstitution of the Russell indexes [1][2] - This inclusion is expected to enhance the company's visibility within the investment community and is seen as a significant achievement in broadening awareness and engagement [3] Market Context - The Russell 3000® Index includes the 4,000 largest US stocks ranked by total market capitalization as of April 30, 2025, and membership lasts for one year [2] - Membership in the Russell 3000® Index also grants automatic inclusion in either the large-cap Russell 1000® Index or the small-cap Russell 2000® Index, along with relevant growth and value style indexes [2] Industry Impact - The Russell indexes are widely utilized by investment managers and institutional investors, with approximately $10.6 trillion in assets benchmarked against them as of June 2024 [3] - FTSE Russell, the provider of these indexes, is recognized for its objective market capitalization and style attributes in determining membership [2][3]

Core Insights - Clover Health reported strong financial results for Q1 2025, with significant growth in membership and profitability, reflecting the effectiveness of its strategic plan [2][3][5] - The company has improved its full-year 2025 guidance, maintaining expectations for insurance revenue and adjusted EBITDA while increasing projected adjusted net income [6][5] Financial Performance - Insurance revenue for Q1 2025 reached $456.9 million, a 33.7% increase from $341.7 million in Q1 2024 [3][5] - Total revenues for Q1 2025 were $462.3 million, up 33.3% year-over-year [3][5] - Adjusted net income from continuing operations was $25.3 million, a 321.7% increase compared to $6.0 million in Q1 2024 [3][5] - Adjusted EBITDA for Q1 2025 was $25.8 million, reflecting a 279.4% increase from $6.8 million in the same quarter last year [3][5] Membership Growth - Average Medicare Advantage membership increased to 101,959 in Q1 2025, representing a 28.6% growth from 79,265 in Q1 2024 [3][5] - The company expects average Medicare Advantage membership to be between 103,000 and 107,000 for the full year 2025, indicating a 30% growth year-over-year at the midpoint [5][6] Cost Management - Medical costs for Q1 2025 were in line with expectations, demonstrating the strength of Clover's technology-driven care management model [5] - Adjusted SG&A as a percentage of total revenues improved to 18.0% in Q1 2025 from 21.6% in Q1 2024, indicating better operational efficiency [3][5] Future Outlook - Clover Health's updated guidance for full-year 2025 includes insurance revenue between $1.800 billion and $1.875 billion, with adjusted EBITDA profitability projected between $50 million and $70 million [6][5] - The company aims to continue strategic investments in its growth model and expand the reach of Clover Assistant to enhance competitive positioning [3][5]

Core Insights - Clover Health Investments, Corp. will report its first quarter 2025 financial results on May 6, 2025, after market close, followed by a conference call at 5:00 p.m. Eastern Time to discuss the results [1][3] Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company's strategy is driven by its software platform, Clover Assistant, which aggregates patient data to support clinical decision-making and improve health outcomes, particularly in managing chronic diseases [2] - Clover Health offers PPO and HMO Medicare Advantage plans across several states, emphasizing its flagship wide-network, high-choice PPO plans [2] - Through its subsidiary, Counterpart Health, Clover Health extends its data-driven technology to a broader audience, aiming to enhance patient outcomes and reduce healthcare costs nationwide [2] - The company has published data showcasing the positive impact of its technology on medication adherence and the early identification and management of diabetes and chronic kidney disease [2]

Core Insights - Clover Health has appointed Dr. Shelly Gupta as Chief Medical Officer, bringing over a decade of Medicare Advantage and healthcare leadership experience [1][2] - Dr. Gupta's role will focus on enhancing clinical operations, quality initiatives, and chronic disease management programs, emphasizing patient choice and provider autonomy [1][3] Company Overview - Clover Health is a physician enablement technology company dedicated to improving access to quality healthcare for Medicare beneficiaries, particularly seniors [5] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes and manage chronic diseases [5] Leadership and Strategy - Dr. Gupta has a proven track record in enhancing clinical outcomes for senior populations, having previously held leadership roles at Humana [2][4] - His expertise in operationalizing clinical innovation aligns with Clover Health's mission to simplify healthcare decisions and empower providers [4] Technology and Innovation - Clover Health's strategy includes leveraging advanced data-driven solutions and innovative technology to optimize Medicare Advantage clinical operations [3][4] - The company aims to enhance care delivery and member satisfaction while advancing value-based care initiatives [3]